Clinical Efficacy of Single-Use of Peroxyl Mouthwash for Reducing Bacteria Saliva and Bioaerosol Contamination Phase 2

Inclusion Criteria: * Potential subjects must meet ALL of the following criteria: * Subjects, ages 18-70, inclusive. * Availability for the duration of this clinical research study. * Good general health. * At least 20 natural teeth. * Gingivitis Index 1.0 (Löe-Silness). * Signed Informed Consent Form Exclusion Criteria: * Potential subjects must NOT HAVE ANY of the following conditions: * Symptoms consistent with COVID-19 or have tested positive. * Presence of orthodontic bands. * Tumor(s) of the soft or hard tissues of the oral cavity. * Advanced periodontal disease (purulent exudate, tooth mobility, and/or extensive loss of periodontal attachment or alveolar bone) or peri-implantitis. * Five or more carious lesions requiring immediate restorative treatment. * Use of antibiotic one-month prior to entry into the study. * Participation in any other clinical study or test panel within the one month prior to entry into the study. * Dental prophylaxis during the past two weeks prior to baseline examinations. * History of allergies to oral care/personal care consumer products or their ingredients. * On any prescription medicines that might interfere with the study outcome. * An existing medical condition that prohibits not eating or drinking for periods up to 4 hours. * History of alcohol or drug abuse. * Self-reported pregnant or lactating subjects.